hotspot
Previous article:
FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article: Testing for cancer recurrence creates a new limbo for patients
Next article: Testing for cancer recurrence creates a new limbo for patients
focus
leisure time
-
Readout Newsletter: What happened with Sarepta's Duchenne data
2025-10-01 03:29 -
STAT Wunderkinds: Ruey Hu's digital tools for parsing research
2025-10-01 03:16 -
STAT Wunderkinds: Ruey Hu's digital tools for parsing research
2025-10-01 03:10 -
Telehealth options flood the market as retailers push virtual care
2025-10-01 02:17 -
Physician subsidies by hospitals soar in wake of No Surprises Act
2025-10-01 02:12 -
STAT Wunderkinds: Ruey Hu's digital tools for parsing research
2025-10-01 01:44